E-LIB Suche - Ergebnisse für: Conkling, Paul

1

Clinical Activity and Safety of Atezolizumab in a Phase 1 S..:

Chiang, Anne C. ; Sequist, Lecia Van Dam ; Gilbert, Jill...
Clinical Lung Cancer. 21 (2020) 5 - p. 455-463.e4 , 2020

Link: https://doi.org/10.1016/..

2

Atezolizumab in patients with advanced non-small cell lung ..:

Gadgeel, Shirish M. ; Lukas, Rimas V. ; Goldschmidt, Jerome...
Lung Cancer. 128 (2019) - p. 105-112 , 2019

Link: https://doi.org/10.1016/..

3

Extended dosing with CC‐486 (oral azacitidine) in patients ..:

Savona, Michael R. ; Kolibaba, Kathryn ; Conkling, Paul...
American Journal of Hematology. 93 (2018) 10 - p. 1199-1206 , 2018

Link: https://doi.org/10.1002/..

4

P1.07-002 G1T28, a Cyclin Dependent Kinase 4/6 Inhibitor, i..:

Hart, Lowell ; Roberts, Patrick ; Ferrarotto, Renata...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S696 , 2017

Link: https://doi.org/10.1016/..

5

A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, C..:

Boccia, Ralph V. ; Bessudo, Alberto ; Agajanian, Richy...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 7 - p. 433-437 , 2017

Link: https://doi.org/10.1016/..

6

A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, C..:

Boccia, Ralph ; Bessudo, Alberto ; Agajanian, Richy...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e14 , 2017

Link: https://doi.org/10.1016/..

7

Antitumor activity and safety of combination therapy with t..:

Smith, David A. ; Conkling, Paul ; Richards, Donald A....
Cancer Immunology, Immunotherapy. 63 (2014) 8 - p. 787-796 , 2014

Link: https://doi.org/10.1007/..

8

A phase I dose-escalation study of MEDI-575, a PDGFRα monoc..:

Becerra, Carlos R. ; Conkling, Paul ; Vogelzang, Nicholas...
Cancer Chemotherapy and Pharmacology. 74 (2014) 5 - p. 917-925 , 2014

Link: https://doi.org/10.1007/..

9

A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizu..:

Uronis, Hope E. ; Bendell, Johanna C. ; Altomare, Ivy...
The Oncologist. 18 (2013) 3 - p. 271-272 , 2013

Link: https://doi.org/10.1634/..

10

Phase 1b study results of IMO-2055, a novel TLR9 agonist, i..:

Smith, David A. ; Conkling, Paul ; Richards, Donald A....
Lung Cancer. 77 (2012) - p. S39 , 2012

Link: https://doi.org/10.1016/..

11

A phase I study of imexon plus gemcitabine as first-line th..:

Cohen, Steven J. ; Zalupski, Mark M. ; Modiano, Manuel R....
Cancer Chemotherapy and Pharmacology. 66 (2009) 2 - p. 287-294 , 2009

Link: https://doi.org/10.1007/..

12

Results of a Phase II study of weekly docetaxel and carbopl..:

Weissman, Charles H. ; Sandbach, John ; Brooker, Reginald...
Lung Cancer. 52 (2006) 3 - p. 313-317 , 2006

Link: https://doi.org/10.1016/..

13

Effect of diethyldithiocarbamate (DDC) on human monocyte fu..:

Conkling, Paul ; Cornwell, David G. ; Sagone Jr., Arthur L.
Inflammation. 9 (1985) 2 - p. 149-161 , 1985

Link: https://doi.org/10.1007/..

14

Real-World Outcomes of Trilaciclib Among Patients with Exte..:

Goldschmidt, Jerome ; Hart, Lowell ; Scott, Jeffrey...
Advances in Therapy. 40 (2023) 10 - p. 4189-4215 , 2023

Link: https://doi.org/10.1007/..

15

Trilaciclib Use and Chemotherapy-Induced Myelosuppression A..:

Goldschmidt, Jerome ; Monnette, Alisha ; Shi, Ping...
International Journal of Cancer Care and Delivery. 2 (2022) Supplement 2 - p. , 2022

Link: https://doi.org/10.53876..